Advertisement
Advertisement

XRTX

XRTX logo

XORTX Therapeutics Inc

0.9815
USD
-0.0785
-7.41%
Jan 17, 11:17 UTC -5
Closed
...

XORTX Therapeutics Inc Profile

About

XORTX Therapeutics Inc. is a pharmaceutical therapeutics company. It focused on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc. is based in CALGARY, Alberta.

Info & Links

CEO

Allen Davidoff

Headquarters

3710 - 33RD STREET NW
ALBERTA, A1 T2L 2M1, CANADA

Auditor

Smythe LLP

Share holders

16

Employees

17

XORTX Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

3.42M

Enterprise Value

1.18M

Enterprise Value/EBITDA(ttm)

-0.27

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.71

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-146.27%

Return on Invested Capital(ttm)

-84.27%

Return on Assets(ttm)

-86.83%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-4.33M

Net Income Available to Common(ttm)

-736.60K

Diluted EPS(ttm)

0.00

Share Statistics

Beta (5Y Monthly)

0.67

52-Week Change

-59.94%

S&P 500 52-Week Change

23.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

3.24M

% Held by Insiders

6.90%

% Held by Institutions

0.23%

Balance Sheet

Total Cash(mrq)

2.30M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

61.50K

Total Debt/Equity(mrq)

2.88%

Current Ratio(mrq)

1.40%

Quick Ratio(mrq)

1.40%

Book Value Per Share(mrq)

0.73

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.96

Free Cash Flow(ytd)

-2.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement